The neuroprotective effect of 2-oxoglutarate in the experimental ischemia of hippocampus

T. N. Kovalenko, G. A. Ushakova, I. Osadchenko, G. G. Skibo, Stefan Pierzynowski

Research output: Contribution to journalArticlepeer-review

17 Citations (SciVal)


In this study we investigated the potential neuroprotective effect of 2-oxoglutarate (2-OG) on the hippocampus in the transient vessel occlusion ischemia model in the Mongolian gerbil. The morphological and biochemical studies were performed at 7 days after occlusion of carotid arteries. The acute reduction of NeuN-positive neurons in the CA1 pyramidal layer of the hippocampus was accompanied by increased staining intensity for GFAP-positive astrocytes, indicative of glial reaction. The neuron death in the CA1 area coincided with a strong 2.4 fold decrease in the membrane forms of neuronal cell adhesion molecules and elevated levels of astrocyte-specific proteins (soluble GFAP to 2,6 times; filament GFAP to 1,5 times; calcium-binding protein S-100b to 1,6 times). Treatment with 2-oxoglutarate (2.28 g/l drinking water) for between 7 and 21 days attenuated the neuronal death and reactive astrogliosis in this model of experimental ischemia by 20-50%. Our results suggest that 2-OG may prevent the disturbances of neural cells that usually take place during ischemic pathology.
Original languageEnglish
Pages (from-to)239-246
JournalJournal of Physiology and Pharmacology
Issue number2
Publication statusPublished - 2011

Subject classification (UKÄ)

  • Zoology


  • 2-oxoglutarate
  • brain
  • glial fibrillary acid protein (GFAP)
  • hippocampus
  • ischemia
  • neural cell adhesion molecule (NCAM)
  • neuronal
  • specific nuclear protein (NeuN)
  • S100 calcium binding protein B (S100b)


Dive into the research topics of 'The neuroprotective effect of 2-oxoglutarate in the experimental ischemia of hippocampus'. Together they form a unique fingerprint.

Cite this